Abstract
Male breast cancer is very rare, especially inflammatory breast cancer, which is an aggressive, rapidly proliferating manifestation of primary breast carcinoma. We present a case report of a 56-year-old man in Lebanon who died 8 months after being diagnosed with inflammatory breast cancer.
MeSH terms
-
Adenocarcinoma / complications
-
Adenocarcinoma / diagnosis*
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / pathology
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Breast Neoplasms, Male / complications
-
Breast Neoplasms, Male / diagnosis*
-
Breast Neoplasms, Male / drug therapy
-
Breast Neoplasms, Male / pathology
-
Cyclophosphamide / administration & dosage
-
Doxorubicin / administration & dosage
-
Edema / etiology
-
Fatal Outcome
-
Fluorouracil / administration & dosage
-
Follow-Up Studies
-
Humans
-
Inflammation / etiology
-
Lymphatic Diseases / etiology
-
Male
-
Middle Aged
-
Neck
-
Thorax
Substances
-
Doxorubicin
-
Cyclophosphamide
-
Fluorouracil